Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
1998 1
2002 2
2003 2
2004 4
2005 11
2006 6
2007 4
2008 2
2009 5
2010 5
2011 8
2012 11
2013 4
2014 5
2015 6
2016 2
2017 2
2018 1
2019 3
2022 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
Nanobodies that Neutralize HIV.
Weiss RA, Verrips CT. Weiss RA, et al. Among authors: verrips ct. Vaccines (Basel). 2019 Jul 31;7(3):77. doi: 10.3390/vaccines7030077. Vaccines (Basel). 2019. PMID: 31370301 Free PMC article. Review.
Structural basis for llama nanobody recognition and neutralization of HIV-1 at the CD4-binding site.
Zhou T, Chen L, Gorman J, Wang S, Kwon YD, Lin BC, Louder MK, Rawi R, Stancofski ED, Yang Y, Zhang B, Quigley AF, McCoy LE, Rutten L, Verrips T, Weiss RA; VRC Production Program; Doria-Rose NA, Shapiro L, Kwong PD. Zhou T, et al. Among authors: verrips t. Structure. 2022 Jun 2;30(6):862-875.e4. doi: 10.1016/j.str.2022.03.012. Epub 2022 Apr 11. Structure. 2022. PMID: 35413243 Free PMC article.
Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions.
Schriek AI, van Haaren MM, Poniman M, Dekkers G, Bentlage AEH, Grobben M, Vidarsson G, Sanders RW, Verrips T, Geijtenbeek TBH, Heukers R, Kootstra NA, de Taeye SW, van Gils MJ. Schriek AI, et al. Among authors: verrips t. Front Immunol. 2022 May 16;13:893648. doi: 10.3389/fimmu.2022.893648. eCollection 2022. Front Immunol. 2022. PMID: 35651621 Free PMC article.
Selection of VHHs under application conditions.
Dolk E, Verrips T, de Haard H. Dolk E, et al. Among authors: verrips t. Methods Mol Biol. 2012;911:199-209. doi: 10.1007/978-1-61779-968-6_13. Methods Mol Biol. 2012. PMID: 22886254
Towards an ultra-rapid smartphone- connected test for infectious diseases.
Turbé V, Gray ER, Lawson VE, Nastouli E, Brookes JC, Weiss RA, Pillay D, Emery VC, Verrips CT, Yatsuda H, Athey D, McKendry RA. Turbé V, et al. Among authors: verrips ct. Sci Rep. 2017 Sep 20;7(1):11971. doi: 10.1038/s41598-017-11887-6. Sci Rep. 2017. PMID: 28931860 Free PMC article.
CXCR4-targeting nanobodies differentially inhibit CXCR4 function and HIV entry.
Van Hout A, Klarenbeek A, Bobkov V, Doijen J, Arimont M, Zhao C, Heukers R, Rimkunas R, de Graaf C, Verrips T, van der Woning B, de Haard H, Rucker JB, Vermeire K, Handel T, Van Loy T, Smit MJ, Schols D. Van Hout A, et al. Among authors: verrips t. Biochem Pharmacol. 2018 Dec;158:402-412. doi: 10.1016/j.bcp.2018.10.015. Epub 2018 Oct 17. Biochem Pharmacol. 2018. PMID: 30342024
Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions.
Schriek AI, van Haaren MM, Poniman M, Dekkers G, Bentlage AEH, Grobben M, Vidarsson G, Sanders RW, Verrips T, Geijtenbeek TBH, Heukers R, Kootstra NA, de Taeye SW, van Gils MJ. Schriek AI, et al. Among authors: verrips t. Front Immunol. 2022 Nov 22;13:1091668. doi: 10.3389/fimmu.2022.1091668. eCollection 2022. Front Immunol. 2022. PMID: 36483568 Free PMC article.
78 results